<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2019 [PPXK5GW761L0VHU0EUGE]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:10pt Times New Roman;margin:0'><B>UNITED STATES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Washington, D. C. 20549</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Pursuant to Section 13 Or 15(d) of the</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Securities Exchange Act of 1934</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Date of Report (Date of earliest event reported): June 17, 2019 </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>GB Sciences, Inc.</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Exact name of Registrant as specified in its charter)</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>Delaware</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(State or other Jurisdiction of <BR>Incorporation or organization)</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>000-55462</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Commission File Number)</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>59-3733133</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(IRS Employer I.D. No.)</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>3550 W. Teco Avenue</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Las Vegas, Nevada 89118  </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Phone: (844) 843-2569</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Address, including zip code, and telephone number, including area code, of</P>
<P align=center style='font:10pt Times New Roman;margin:0'>registrant&#8217;s principal executive offices)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>N/A</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Former name, former address and former fiscal year, if changed since last report)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt> &nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt> &nbsp;Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt> &nbsp;Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt> &nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><FONT style=font-size:10pt><B>ITEM 3.03  Material Modification to Rights of Security Holders</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><FONT style=font-size:10pt>On June 17, 2019, the Registrant commenced allowing the exercise of its outstanding common stock warrants at the reduced exercise price of $.10 per share. &nbsp;&nbsp;The reduced exercise price terminates on July 11, 2019.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>SIGNATURE PAGE</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;&nbsp;GB Sciences, Inc.</B></FONT></P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Dated: June 21, 2019</FONT></P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>By: </FONT></P>
</TD><TD valign=top style='border-bottom:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><FONT style=font-size:10pt>/s/ Ksenia Griswold</FONT></P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><FONT style=font-size:10pt>Ksenia Griswold</FONT></P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><FONT style=font-size:10pt>Chief Financial Officer </FONT></P>
</TD><TD valign=middle><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:15pt 0 0 0'><P align=center style='font:10pt Calibri;margin:0'>1</P>
<P style='font:10pt Calibri;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "gblx_8k.htm", "description": "8-K", "secsgml_size_bytes": 8952}]
{"company-data": {"conformed-name": "GB SCIENCES INC", "cik": "0001165320", "assigned-sic": "1311", "irs-number": "593733133", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-55462", "film-number": "19912254"}, "business-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118", "phone": "(844) 843-2569"}, "mail-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118"}, "former-company": [{"former-conformed-name": "Growblox Sciences, Inc.", "date-changed": "20140603"}, {"former-conformed-name": "Signature Exploration & Production Corp.", "date-changed": "20080602"}, {"former-conformed-name": "Diabetic Treatment Centers of America, Inc.", "date-changed": "20040812"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 17, 2019
GB Sciences, Inc.
(Exact name of Registrant as specified in its charter)
Delaware
(State or other Jurisdiction of
Incorporation or organization)
000-55462
(Commission File Number)
59-3733133
(IRS Employer I.D. No.)
3550 W. Teco Avenue
Las Vegas, Nevada 89118
Phone: (844) 843-2569
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)
☐
Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))
ITEM 3.03  Material Modification to Rights of Security Holders
On June 17, 2019, the Registrant commenced allowing the exercise of its outstanding common stock warrants at the reduced exercise price of $.10 per share.   The reduced exercise price terminates on July 11, 2019.
SIGNATURE PAGE
Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GB Sciences, Inc.
Dated: June 21, 2019
By:
/s/ Ksenia Griswold
Ksenia Griswold
Chief Financial Officer
1